Floral Remedies for Sleep-bruxism Patients
NCT03112954 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2017-04-13
Summary
Introduction: Bruxism is a parafunctional habit that affects the stomatognathic system and its support structures. Usually associated with stress and mostly occurring at night, bruxism leads to sleep disorders and daily tension headaches. Aiming to rebalance the emotional and physical state of patients, floral-essence therapy lacks side effects or drug interactions, and has been recognized by the World Health Organization. Aim and Methods: The investigators created a buccal-relaxant formula, combining 8 floral essences and testing it in a double-blind clinical assay conducted in bruxism patients. Results: An alcohol solution of the buccal relaxant containing Daughter of Gaia floral essences of Taraxacum officinale, Antirrhinum majus, Fuchsia × hybrida, Bidens bipinnata, Campanula carpatica, Achyrocline, Nymphaea caerulea, and Tetraoensis riparia significantly attenuated temporal headaches in the bruxism patients compared to the placebo group (69.46%±1.79 versus 3.55%±1.37, P=0.0001). Moreover, patients after 21 days using the buccal relaxant increased their quality of sleep and experienced attenuated jaw-muscle rigidity or morning mouth-opening difficulties. Less masseter hypertrophy and reduced sensitivity due to abfraction of enamel facets were noted as well. Conclusions: The buccal-relaxant formula may have sedative properties, preventing daily temporal headaches in sleep-bruxism patients, suggesting a muscle-relaxation effect. Although the results are promising, long-term studies are needed to clarify the pharmacological mechanism of each floral essence in the buccal-relaxant formula and their tolerance effects.
Conditions
- Temporal Cephalic Pain
Interventions
- DRUG
-
Buccal-relaxant formula
Following physical examinations, 60 patients were randomly allocated to 2 groups of 30 patients each, who had been diagnosed with sleep bruxism. Each patient received a small amber glass bottle containing the floral remedy and was instructed to use four drops sublingually 4 times a day for 22 days. All examiners were different professionals, with no contact among each other, as follows: an examiner who conducted the physical examination, an examiner who randomly divided the patients, and an examiner who prepared the floral and placebo remedies. At the end of the study, each group of 30 patients was re-named: Group F, the group of patients who received the floral remedy.
- DRUG
-
30 patients diagnosed with sleep bruxism received a small amber glass bottle containing the saline solution and was instructed to use four drops sublingually 4 times a day for 22 days. All examiners were different professionals, with no contact among each other, as follows: an examiner who conducted the physical examination, an examiner who randomly divided the patients, and an examiner who prepared the floral and placebo remedies. At the end of the study, each group of 30 patients was re-named: Group P, the group of patients who received the placebo.
Sponsors & Collaborators
-
Universidade Federal Fluminense
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-29
- Primary Completion
- 2014-06-11
- Completion
- 2014-06-20
Countries
- Brazil
Study Locations
More Related Trials
-
Flumazenil for the Treatment of Primary Hypersomnia
NCT01183312 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Placebo Impacts Sleep and Pain Modulation in Chronic Pain
NCT06225817 ·Status: RECRUITING ·Phase: NA
-
An Observation Study on Neuropsychology and Serum Melatonin Level in Patients With Medication Overuse Headache
NCT03655184 ·Status: UNKNOWN
-
Non-deceptive Application of Placebos in Insomnia
NCT03616652 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
NCT05536596 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)
NCT00094627 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study of TS-142 in Patients with Insomnia
NCT05453136 ·Status: COMPLETED ·Phase: PHASE3
-
Melatonin Treatment for Induced Transient Insomnia
NCT00950885 ·Status: COMPLETED ·Phase: NA
-
Effects of Caffeine on Sleep-wake Regulation in Teenagers
NCT04321785 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of the Herbal Medicine Sominex ® (Passiflora Incarnata L., Valeriana Officinalis L. and Crataegus Oxyacantha L.), Manufactured by the Laboratory EMS S / A in Patients With Psychophysiological Insomnia
NCT01100645 ·Status: UNKNOWN ·Phase: PHASE3
-
Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study
NCT01114373 ·Status: COMPLETED ·Phase: PHASE2
-
Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes
NCT05511818 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin
NCT02127736 ·Status: COMPLETED ·Phase: NA
-
Melatonin in Patients Under Carotid Endarterectomy
NCT03115034 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Formulation for Sleep Among People With Poor Sleep Quality
NCT05609890 ·Status: COMPLETED ·Phase: NA
-
Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults
NCT01071889 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease
NCT02940912 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Nutritional Supplementation on Sleep Quality
NCT06935123 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Gaboxadol in Primary Insomnia
NCT00209924 ·Status: COMPLETED ·Phase: PHASE3
-
Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic
NCT02818569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
NCT00352144 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Sleep-relieving Effect of Banana Peel Extract
NCT05130359 ·Status: COMPLETED ·Phase: NA
-
PASCONAL NERVENTROPFEN in the Treatment of Nervous Diseases
NCT01125605 ·Status: COMPLETED
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423 ·Status: COMPLETED ·Phase: PHASE2
-
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
NCT00280436 ·Status: COMPLETED ·Phase: PHASE2